Deactivation of 12(S)-HETE through (-1)-hydroxylation and -oxidation in alternatively activated macrophages

Tamas Kriska, Michael J. Thomas, J R Falck, William B. Campbell

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Polarization of macrophages to proinflammatory M1 and to antiinflammatory alternatively activated M2 states has physiological implications in the development of experimental hypertension and other pathological conditions. 12/15-Lipoxygenase (12/15-LO) and its enzymatic products 12(S)- and 15(S)-hydroxyeicosatetraenoic acid (HETE) are essential in the process since disruption of the gene encoding 12/15-LO renders the mice unsusceptible to hypertension. The objective was to test the hypothesis that M2 macrophages catabolize 12(S)-HETE into products that are incapable of promoting vasoconstriction. Cultured M2 macrophages metabolized externally added [14C]12(S)-HETE into more polar metabolites, while M1 macrophages had little effect on the catabolism. The major metabolites were identified by mass spectrometry as (-1)-hydroxylation and -oxidation products. The conversion was inhibited by both peroxisomal -oxidation inhibitor, thioridazine, and cytochrome P450 inhibitors. Quantitative PCR analysis confirmed that several cytochrome P450 enzymes (CYP2E1 and CYP1B1) and peroxisomal -oxidation markers were upregulated upon M2 polarization. The identified 12,19-dihydroxy-5,8,10,14-eicosatetraenoic acid and 8-hydroxy-6,10-hexadecadienoic acid metabolites were tested on abdominal aortic rings for biological activity. While 12(S)-HETE enhanced vasocon-strictions to angiotensin II from 15% to 25%, the metabolites did not. These results indicate that M2, but not M1, macrophages degrade 12(S)-HETE into products that no longer enhance the angiotensin II-induced vascular constriction, supporting a possible antihypertensive role of M2 macrophages.

Original languageEnglish (US)
Pages (from-to)615-624
Number of pages10
JournalJournal of Lipid Research
Volume59
Issue number4
DOIs
StatePublished - Jan 1 2018

Fingerprint

12-Hydroxy-5,8,10,14-eicosatetraenoic Acid
Hydroxylation
Macrophages
Metabolites
Oxidation
Cytochrome P-450 Enzyme System
Corrosion inhibitors
Angiotensin II
Polarization
Naphazoline
Arachidonic Acids
Thioridazine
Hypertension
Hydroxyeicosatetraenoic Acids
Cytochrome P-450 CYP2E1
Gene encoding
Bioactivity
Vasoconstriction
Constriction
Antihypertensive Agents

Keywords

  • 12(S)-HETE metabolism
  • 12/15-lipoxygenase
  • Angiotensin II
  • Cytochrome P450

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Cell Biology

Cite this

Deactivation of 12(S)-HETE through (-1)-hydroxylation and -oxidation in alternatively activated macrophages. / Kriska, Tamas; Thomas, Michael J.; Falck, J R; Campbell, William B.

In: Journal of Lipid Research, Vol. 59, No. 4, 01.01.2018, p. 615-624.

Research output: Contribution to journalArticle

Kriska, Tamas ; Thomas, Michael J. ; Falck, J R ; Campbell, William B. / Deactivation of 12(S)-HETE through (-1)-hydroxylation and -oxidation in alternatively activated macrophages. In: Journal of Lipid Research. 2018 ; Vol. 59, No. 4. pp. 615-624.
@article{6d767d59ad43488f987dcb631404ac1b,
title = "Deactivation of 12(S)-HETE through (-1)-hydroxylation and -oxidation in alternatively activated macrophages",
abstract = "Polarization of macrophages to proinflammatory M1 and to antiinflammatory alternatively activated M2 states has physiological implications in the development of experimental hypertension and other pathological conditions. 12/15-Lipoxygenase (12/15-LO) and its enzymatic products 12(S)- and 15(S)-hydroxyeicosatetraenoic acid (HETE) are essential in the process since disruption of the gene encoding 12/15-LO renders the mice unsusceptible to hypertension. The objective was to test the hypothesis that M2 macrophages catabolize 12(S)-HETE into products that are incapable of promoting vasoconstriction. Cultured M2 macrophages metabolized externally added [14C]12(S)-HETE into more polar metabolites, while M1 macrophages had little effect on the catabolism. The major metabolites were identified by mass spectrometry as (-1)-hydroxylation and -oxidation products. The conversion was inhibited by both peroxisomal -oxidation inhibitor, thioridazine, and cytochrome P450 inhibitors. Quantitative PCR analysis confirmed that several cytochrome P450 enzymes (CYP2E1 and CYP1B1) and peroxisomal -oxidation markers were upregulated upon M2 polarization. The identified 12,19-dihydroxy-5,8,10,14-eicosatetraenoic acid and 8-hydroxy-6,10-hexadecadienoic acid metabolites were tested on abdominal aortic rings for biological activity. While 12(S)-HETE enhanced vasocon-strictions to angiotensin II from 15{\%} to 25{\%}, the metabolites did not. These results indicate that M2, but not M1, macrophages degrade 12(S)-HETE into products that no longer enhance the angiotensin II-induced vascular constriction, supporting a possible antihypertensive role of M2 macrophages.",
keywords = "12(S)-HETE metabolism, 12/15-lipoxygenase, Angiotensin II, Cytochrome P450",
author = "Tamas Kriska and Thomas, {Michael J.} and Falck, {J R} and Campbell, {William B.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1194/jlr.M081448",
language = "English (US)",
volume = "59",
pages = "615--624",
journal = "Journal of Lipid Research",
issn = "0022-2275",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "4",

}

TY - JOUR

T1 - Deactivation of 12(S)-HETE through (-1)-hydroxylation and -oxidation in alternatively activated macrophages

AU - Kriska, Tamas

AU - Thomas, Michael J.

AU - Falck, J R

AU - Campbell, William B.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Polarization of macrophages to proinflammatory M1 and to antiinflammatory alternatively activated M2 states has physiological implications in the development of experimental hypertension and other pathological conditions. 12/15-Lipoxygenase (12/15-LO) and its enzymatic products 12(S)- and 15(S)-hydroxyeicosatetraenoic acid (HETE) are essential in the process since disruption of the gene encoding 12/15-LO renders the mice unsusceptible to hypertension. The objective was to test the hypothesis that M2 macrophages catabolize 12(S)-HETE into products that are incapable of promoting vasoconstriction. Cultured M2 macrophages metabolized externally added [14C]12(S)-HETE into more polar metabolites, while M1 macrophages had little effect on the catabolism. The major metabolites were identified by mass spectrometry as (-1)-hydroxylation and -oxidation products. The conversion was inhibited by both peroxisomal -oxidation inhibitor, thioridazine, and cytochrome P450 inhibitors. Quantitative PCR analysis confirmed that several cytochrome P450 enzymes (CYP2E1 and CYP1B1) and peroxisomal -oxidation markers were upregulated upon M2 polarization. The identified 12,19-dihydroxy-5,8,10,14-eicosatetraenoic acid and 8-hydroxy-6,10-hexadecadienoic acid metabolites were tested on abdominal aortic rings for biological activity. While 12(S)-HETE enhanced vasocon-strictions to angiotensin II from 15% to 25%, the metabolites did not. These results indicate that M2, but not M1, macrophages degrade 12(S)-HETE into products that no longer enhance the angiotensin II-induced vascular constriction, supporting a possible antihypertensive role of M2 macrophages.

AB - Polarization of macrophages to proinflammatory M1 and to antiinflammatory alternatively activated M2 states has physiological implications in the development of experimental hypertension and other pathological conditions. 12/15-Lipoxygenase (12/15-LO) and its enzymatic products 12(S)- and 15(S)-hydroxyeicosatetraenoic acid (HETE) are essential in the process since disruption of the gene encoding 12/15-LO renders the mice unsusceptible to hypertension. The objective was to test the hypothesis that M2 macrophages catabolize 12(S)-HETE into products that are incapable of promoting vasoconstriction. Cultured M2 macrophages metabolized externally added [14C]12(S)-HETE into more polar metabolites, while M1 macrophages had little effect on the catabolism. The major metabolites were identified by mass spectrometry as (-1)-hydroxylation and -oxidation products. The conversion was inhibited by both peroxisomal -oxidation inhibitor, thioridazine, and cytochrome P450 inhibitors. Quantitative PCR analysis confirmed that several cytochrome P450 enzymes (CYP2E1 and CYP1B1) and peroxisomal -oxidation markers were upregulated upon M2 polarization. The identified 12,19-dihydroxy-5,8,10,14-eicosatetraenoic acid and 8-hydroxy-6,10-hexadecadienoic acid metabolites were tested on abdominal aortic rings for biological activity. While 12(S)-HETE enhanced vasocon-strictions to angiotensin II from 15% to 25%, the metabolites did not. These results indicate that M2, but not M1, macrophages degrade 12(S)-HETE into products that no longer enhance the angiotensin II-induced vascular constriction, supporting a possible antihypertensive role of M2 macrophages.

KW - 12(S)-HETE metabolism

KW - 12/15-lipoxygenase

KW - Angiotensin II

KW - Cytochrome P450

UR - http://www.scopus.com/inward/record.url?scp=85045010822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045010822&partnerID=8YFLogxK

U2 - 10.1194/jlr.M081448

DO - 10.1194/jlr.M081448

M3 - Article

VL - 59

SP - 615

EP - 624

JO - Journal of Lipid Research

JF - Journal of Lipid Research

SN - 0022-2275

IS - 4

ER -